Skip to main content
VCbacked
Log inGet Started

Addition Therapeutics

South San Francisco, United States

Addition Therapeutics develops RNA-only therapeutics using PRINT technology for genetic medicine.

$100.0M raised
Dec 2025
Series A
BiotechnologyHealth CareLife SciencePharmaceutical

Top Investors

Bill & Melinda Gates FoundationAbingworthSR OneOUP (Osage University Partners)Pivotal Life Sciences

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Addition Therapeutics

How much funding has Addition Therapeutics raised?
Addition Therapeutics has raised $100.0M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Who are Addition Therapeutics's investors?
Addition Therapeutics's investors include Bill & Melinda Gates Foundation, Abingworth, SR One, OUP (Osage University Partners), Pivotal Life Sciences.
Where is Addition Therapeutics headquartered?
Addition Therapeutics is headquartered in South San Francisco, United States.
What does Addition Therapeutics do?
Addition Therapeutics develops RNA-only therapeutics using PRINT technology for genetic medicine.
What stage is Addition Therapeutics at?
Addition Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Addition Therapeutics — Funding & Investors." VCBacked, December 17, 2025, https://www.vcbacked.co/company/addition-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2025). Addition Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/addition-therapeutics
Wikipedia (cite web)
{{cite web |title=Addition Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/addition-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong